Medpace’s Central Labs Expand Microbiology Services
Medpace is proud to announce the expansion of our microbiology capabilities at our state-of-the-art central laboratories in Cincinnati, Ohio, and...
Global Infectious Diseases & Vaccines Team – Clinical Operations Experts
In the following video series, Medpace experts across North America, Europe, Latin America, and Asia Pacific will explore how our ID&V team enhances the success…
Innovations in Infectious Diseases & Vaccines Clinical Development – Highlights from ESCMID Global 2024
Medpace infectious diseases and vaccines experts share key takeaways from ESCMID Global 2024 in Barcelona, Spain.
[Webinar] Women’s Health Month Panel
On May 28th, International Day of Action for Womens Health, the Medpace Women’s Health Leadership team is hosting a webinar panel entitled, “The Evolving Women's…
The Medpace Data Integrity Unit
Learn about our team comprised of highly trained microbiology specialists that provide ongoing evaluation and oversight of the microbiology aspects of infectious diseases studies.
Medpace Expands Infectious Diseases & Vaccines Medical Leadership Team
Medpace is pleased to announce that Dr. Arlene Dent has joined Medpace’s infectious diseases and vaccines medical leadership team.
Medpace Expands Vaccines and Women’s Health Leadership Team
Medpace is pleased to announce the addition of a new clinical operations expert, Beth Tulip, to its leadership team. In this interview, we learn more…
A New Paradigm in Infectious Diseases Treatment & Prophylaxis Shaped by the Current Pandemic
The COVID-19 pandemic will end, or as any pandemic in the past, will lose its momentum. Yet, the precedents and the new paradigms formed in…
Webinar: Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID-19 Pandemic
Join AMR experts from Medpace, IHMA, and GARDP as they discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize…
Infectious Diseases in the Immunocompromised Host
An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.